Insider Trading & Ownership - McWherter Charles

Real time insider trading transaction history:

  • Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Insider Trading Transactions for McWherter Charles
Common stock purchase or sale:
Transaction
Date
Reported
DateTime
CompanySymbolInsider
Relationship
Shares
Traded
Average
Price
Total
Amount
Shares
Owned
Filing
2024-01-19
Sale
2024-01-22
6:59 pm
CymaBay Therapeutics Inc.CBAYMcWherter Charles
President of R&D
18,403$23.67$435,645446,597
(Direct)
View
2023-12-18
Sale
2023-12-18
8:04 pm
CymaBay Therapeutics Inc.CBAYMcWherter Charles
President of R&D
11,332$21.48$243,44115,000
(Direct)
View
2023-11-17
Sale
2023-11-17
5:58 pm
CymaBay Therapeutics Inc.CBAYMcWherter Charles
President of R&D
11,342$18.28$207,29326,332
(Direct)
View
2023-10-18
Sale
2023-10-18
6:22 pm
CymaBay Therapeutics Inc.CBAYMcWherter Charles
President of R&D
21,743$14.07$305,94137,674
(Direct)
View
2023-09-18
Sale
2023-09-19
5:27 pm
CymaBay Therapeutics Inc.CBAYMcWherter Charles
President of R&D
21,746$16.22$352,73359,417
(Direct)
View
2023-08-18
Sale
2023-08-18
7:03 pm
CymaBay Therapeutics Inc.CBAYMcWherter Charles
President of R&D
21,746$11.47$249,35981,163
(Direct)
View
2023-07-18
Sale
2023-07-19
6:05 pm
CymaBay Therapeutics Inc.CBAYMcWherter Charles
President of R&D
21,749$11.43$248,519102,909
(Direct)
View
2023-06-20
Sale
2023-06-21
6:46 pm
CymaBay Therapeutics Inc.CBAYMcWherter Charles
President of R&D
21,749$8.1559$177,383124,658
(Direct)
View
2023-05-18
Sale
2023-05-19
6:00 pm
CymaBay Therapeutics Inc.CBAYMcWherter Charles
President of R&D
21,749$9.0757$197,387146,407
(Direct)
View

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date
Reported
DateTime
Exercisable
Expiration
CompanySymnbolInsider
Relationship
Shares
Traded
Conversion
Price
Shares
Owned
Filing
2024-08-05
Option Award
2024-08-07
6:05 pm
N/A
2034-08-05
89bio Inc.ETNBMcWherter Charles
Director
67,700$067,700
(Direct)
View
2024-03-22
Disposition
2024-03-22
5:06 pm
N/A
2025-01-06
CymaBay Therapeutics Inc.CBAYMcWherter Charles
President of R&D
1,735,350$00
(Direct)
View
2024-01-24
Option Award
2024-01-26
6:29 pm
N/A
2034-01-23
CymaBay Therapeutics Inc.CBAYMcWherter Charles
President of R&D
150,563$0165,563
(Direct)
View
2024-01-19
Exercise
2024-01-22
6:59 pm
N/A
N/A
CymaBay Therapeutics Inc.CBAYMcWherter Charles
President of R&D
8,334$10446,597
(Direct)
View
2024-01-19
Exercise
2024-01-22
6:59 pm
N/A
N/A
CymaBay Therapeutics Inc.CBAYMcWherter Charles
President of R&D
2,250$1.06446,597
(Direct)
View
2024-01-19
Exercise
2024-01-22
6:59 pm
N/A
N/A
CymaBay Therapeutics Inc.CBAYMcWherter Charles
President of R&D
1,916$1.82446,597
(Direct)
View
2024-01-19
Exercise
2024-01-22
6:59 pm
N/A
2026-01-25
CymaBay Therapeutics Inc.CBAYMcWherter Charles
President of R&D
18,403$0446,597
(Direct)
View
2024-01-19
Exercise
2024-01-22
6:59 pm
N/A
N/A
CymaBay Therapeutics Inc.CBAYMcWherter Charles
President of R&D
2,778$1.72446,597
(Direct)
View
2024-01-19
Exercise
2024-01-22
6:59 pm
N/A
N/A
CymaBay Therapeutics Inc.CBAYMcWherter Charles
President of R&D
3,125$11.69446,597
(Direct)
View
2023-12-18
Exercise
2023-12-18
8:04 pm
N/A
2023-12-22
CymaBay Therapeutics Inc.CBAYMcWherter Charles
President of R&D
11,332$015,000
(Direct)
View
2023-12-18
Exercise
2023-12-18
8:04 pm
N/A
N/A
CymaBay Therapeutics Inc.CBAYMcWherter Charles
President of R&D
11,332$515,000
(Direct)
View
2023-11-17
Exercise
2023-11-17
5:58 pm
N/A
2023-12-22
CymaBay Therapeutics Inc.CBAYMcWherter Charles
President of R&D
11,342$026,332
(Direct)
View
2023-11-17
Exercise
2023-11-17
5:58 pm
N/A
N/A
CymaBay Therapeutics Inc.CBAYMcWherter Charles
President of R&D
11,342$526,332
(Direct)
View
2023-10-18
Exercise
2023-10-18
6:22 pm
N/A
2023-10-30
CymaBay Therapeutics Inc.CBAYMcWherter Charles
President of R&D
21,743$037,674
(Direct)
View
2023-10-18
Exercise
2023-10-18
6:22 pm
N/A
N/A
CymaBay Therapeutics Inc.CBAYMcWherter Charles
President of R&D
21,743$537,674
(Direct)
View
2023-09-18
Exercise
2023-09-19
5:27 pm
N/A
2023-10-30
CymaBay Therapeutics Inc.CBAYMcWherter Charles
President of R&D
21,746$059,417
(Direct)
View
2023-09-18
Exercise
2023-09-19
5:27 pm
N/A
N/A
CymaBay Therapeutics Inc.CBAYMcWherter Charles
President of R&D
21,746$559,417
(Direct)
View
2023-08-18
Exercise
2023-08-18
7:03 pm
N/A
2023-10-30
CymaBay Therapeutics Inc.CBAYMcWherter Charles
President of R&D
21,746$081,163
(Direct)
View
2023-08-18
Exercise
2023-08-18
7:03 pm
N/A
N/A
CymaBay Therapeutics Inc.CBAYMcWherter Charles
President of R&D
21,746$581,163
(Direct)
View
2023-07-18
Exercise
2023-07-19
6:05 pm
N/A
2023-10-30
CymaBay Therapeutics Inc.CBAYMcWherter Charles
President of R&D
21,749$0102,909
(Direct)
View
2023-07-18
Exercise
2023-07-19
6:05 pm
N/A
N/A
CymaBay Therapeutics Inc.CBAYMcWherter Charles
President of R&D
21,749$5102,909
(Direct)
View
2023-06-20
Exercise
2023-06-21
6:46 pm
N/A
2023-10-30
CymaBay Therapeutics Inc.CBAYMcWherter Charles
President of R&D
21,749$0124,658
(Direct)
View
2023-06-20
Exercise
2023-06-21
6:46 pm
N/A
N/A
CymaBay Therapeutics Inc.CBAYMcWherter Charles
President of R&D
21,749$5124,658
(Direct)
View
2023-05-18
Exercise
2023-05-19
6:00 pm
N/A
2023-10-30
CymaBay Therapeutics Inc.CBAYMcWherter Charles
President of R&D
21,749$0146,407
(Direct)
View
2023-05-18
Exercise
2023-05-19
6:00 pm
N/A
N/A
CymaBay Therapeutics Inc.CBAYMcWherter Charles
President of R&D
21,749$5146,407
(Direct)
View
2023-01-25
Option Award
2023-01-27
4:27 pm
N/A
2033-01-24
CymaBay Therapeutics Inc.CBAYMcWherter Charles
President of R&D
300,000$0300,000
(Direct)
View
2022-01-25
Option Award
2022-01-27
4:55 pm
N/A
2032-01-24
CymaBay Therapeutics Inc.CBAYMcWherter Charles
Chief Scientific Officer
225,000$0225,000
(Direct)
View
2021-01-26
Option Award
2021-01-28
2:57 pm
N/A
2031-01-25
CymaBay Therapeutics Inc.CBAYMcWherter Charles
Chief Scientific Officer
112,000$0112,000
(Direct)
View
2020-05-15
Option Award
2020-05-19
5:14 pm
N/A
2030-05-14
CymaBay Therapeutics Inc.CBAYMcWherter Charles
SVP & Chief Scientific Officer
328,299$0328,299
(Direct)
View